Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Vycor Medical (VYCO) Depreciation and Depletion (2016 - 2025)

Vycor Medical has reported Depreciation and Depletion over the past 16 years, most recently at $16144.0 for Q4 2025.

  • Quarterly Depreciation and Depletion fell 4.3% to $16144.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $63143.0 through Dec 2025, down 1.2% year-over-year, with the annual reading at $63143.0 for FY2025, 1.2% down from the prior year.
  • Depreciation and Depletion was $16144.0 for Q4 2025 at Vycor Medical, up from $15868.0 in the prior quarter.
  • Over five years, Depreciation and Depletion peaked at $16869.0 in Q4 2024 and troughed at $11162.0 in Q1 2021.
  • The 5-year median for Depreciation and Depletion is $15401.0 (2021), against an average of $15313.8.
  • Year-over-year, Depreciation and Depletion skyrocketed 54.36% in 2021 and then decreased 4.3% in 2025.
  • A 5-year view of Depreciation and Depletion shows it stood at $15404.0 in 2021, then fell by 0.48% to $15330.0 in 2022, then fell by 1.49% to $15102.0 in 2023, then rose by 11.7% to $16869.0 in 2024, then dropped by 4.3% to $16144.0 in 2025.
  • Per Business Quant, the three most recent readings for VYCO's Depreciation and Depletion are $16144.0 (Q4 2025), $15868.0 (Q3 2025), and $15021.0 (Q2 2025).